ECO Animal Health Group Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0032036807
GBP
1.10
0.12 (12.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With ROE of 3.12%, it has a expensive valuation with a 0.72 Price to Book Value

  • Over the past year, while the stock has generated a return of 50.68%, its profits have fallen by -1.8%
2

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 70 Million (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.21

stock-summary
Return on Equity

6.07%

stock-summary
Price to Book

0.83

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
49.66%
0%
49.66%
6 Months
80.33%
0%
80.33%
1 Year
50.68%
0%
50.68%
2 Years
3.29%
0%
3.29%
3 Years
4.76%
0%
4.76%
4 Years
-32.31%
0%
-32.31%
5 Years
-54.17%
0%
-54.17%

ECO Animal Health Group Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-0.02%
EBIT Growth (5y)
7.74%
EBIT to Interest (avg)
6.62
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.05
Tax Ratio
34.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.69%
ROE (avg)
6.28%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
0.72
EV to EBIT
8.78
EV to EBITDA
5.27
EV to Capital Employed
0.61
EV to Sales
0.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.95%
ROE (Latest)
3.12%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by ECO Animal Health Group Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2023 is 3.77% vs -22.16% in Mar 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2023 is 542.86% vs -104.43% in Mar 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.30",
          "val2": "82.20",
          "chgp": "3.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.40",
          "val2": "6.50",
          "chgp": "13.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.30",
          "chgp": "133.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.10",
          "val2": "-0.70",
          "chgp": "542.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "59.30%",
          "val2": "55.10%",
          "chgp": "0.42%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Mar'23stock-summary
Mar'23
Mar'22
Change(%)
Net Sales
85.30
82.20
3.77%
Operating Profit (PBDIT) excl Other Income
7.40
6.50
13.85%
Interest
0.70
0.30
133.33%
Exceptional Items
0.00
-2.20
100.00%
Consolidate Net Profit
3.10
-0.70
542.86%
Operating Profit Margin (Excl OI)
59.30%
55.10%
0.42%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2023 is 3.77% vs -22.16% in Mar 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2023 is 542.86% vs -104.43% in Mar 2022

stock-summaryCompany CV
About ECO Animal Health Group Plc stock-summary
stock-summary
ECO Animal Health Group Plc
Pharmaceuticals & Biotechnology
Eco Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The Company's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. The Company's products include Aivlosin and Ecomectin. Aivlosin is an antibiotic that treats a range of specific enteric (gut) and respiratory diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. It operates in the United Kingdom and Europe, the Far East, Latin America, North America, and the Middle East and Africa. Its subsidiaries include Eco Animal Health Limited and ECO Animal Health do Brasil Comercio de Produtos Veterinarios Ltda.
Company Coordinates stock-summary
Company Details
78 Coombe Road , NEW MALDEN None : KT3 4QS
Registrar Details